| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000004314 |
| Receipt No. | R000005150 |
| Official scientific title of the study | Evaluation of Liver Fibrosis in Patients with Chronic Liver Injury via Virtual Touch Tissue Quantification and Hepato-splenic Arterial Resistance |
| Date of disclosure of the study information | 2010/10/04 |
| Last modified on | 2018/10/08 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Evaluation of Liver Fibrosis in Patients with Chronic Liver Injury via Virtual Touch Tissue Quantification and Hepato-splenic Arterial Resistance | |
| Title of the study (Brief title) | VTTQ-HepSAR Trial | |
| Region |
|
|
| Condition | ||
| Condition | Chronic liver injury | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | We examine the evaluation of liver fibrosis in patients with chronic liver injury via virtual touch tissue quantification and hepato-splenic arterial resistance. |
| Basic objectives2 | Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Correlation of degree of the liver fibrosis with speed of the shear elastic wave by virtual touch tissue quantification and hepato-splenic arterial resistance. |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Patients with chronic liver injury or liver cirrhosis were histologically diagnosed by liver biopsy or liver specimen of resected liver.
2.We do not ask whether etiology of chronic liver injury or liver cirrhosis. 3.Patients received document agreement with participation in this study. |
|||
| Key exclusion criteria | 1.A pregnant woman and the patients with the pregnant possibility or the patients nursing a baby.
2.Contraindication of liver biopsy or liver resection. 3.splenectomy or PSE. 4. Patients who judged inappropriate by researcher. |
|||
| Target sample size | 500 | |||
| Research contact person | |
| Name of lead principal investigator | Youichi Morimoto and Yoshitaka Takuma |
| Organization | Kurashiki Central Hospital |
| Division name | Gastroenterology |
| Address | 1-1-1,Miwa, Kurashiki, Okayama |
| TEL | |
| Public contact | |
| Name of contact person | Rui Tamura |
| Organization | Kurashiki Central Hospital |
| Division name | Gastroenterology |
| Address | |
| TEL | |
| Homepage URL | |
| rt12966@kchnet.or.jp | |
| Sponsor | |
| Institute | Department
of Gastroenterology, Kurashiki Central Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Kurashiki Central Hospital |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| URL releasing results | |
| Results | |
| Other related information | 1.Primary Endpoint
We examine the evaluation of liver fibrosis in patients with chronic liver injury via virtual touch tissue quantification and hepato-splenic arterial resistance. 2.Secondary Endpoints We examine the evaluation of liver fibrosis in patients with chronic liver injury via virtual touch tissue quantification and serum non-invasive markers. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000005150 |